Literature DB >> 15473980

Impaired axonal transport and altered axolemmal permeability occur in distinct populations of damaged axons following traumatic brain injury.

James R Stone1, David O Okonkwo, Alfa O Dialo, David G Rubin, Leman K Mutlu, John T Povlishock, Gregory A Helm.   

Abstract

Traumatic axonal injury (TAI) evolves within minutes to hours following traumatic brain injury (TBI). Previous studies have identified axolemmal disruption and impaired axonal transport (AxT) as key mechanisms in the evolution of TAI. While initially hypothesized that axolemmal disruption culminates in impaired AxT, previous studies employed single-label methodologies that did not allow for a full determination of the spatial-temporal relationships of these two events. To explore directly the relationship between impaired AxT and altered axolemmal permeability, the current investigation employed 40, 10, and 3 kDa fluorescently conjugated dextrans as markers of axolemmal integrity, with antibodies targeting the anterogradely transported amyloid precursor protein (APP) utilized as a marker of impaired AxT. Rats underwent impact acceleration TBI and were intrathecally administered 40 kDa, 40 + 10 kDa or 40 + 3 kDa fluorescently tagged dextrans, with brains subsequently prepared for APP immunofluorescence. Brainstem corticospinal tracts (CSpT), medial lemnisci (ML), and medial longitudinal fasciculi were examined for evidence of TAI. APP and all dextrans consistently localized to distinct classes of TAI. Dextrans were noted as early as 5 min following injury within axonal segments demonstrating an irregular/tortuous appearance, and were seen within thin and elongate/vacuolated axons by 30 min-6 h following injury. APP, first noted within swollen axons at 30 min following injury, was found within progressively swollen axons that showed no dextran colocalization within 3 h of injury. However, by 6 h, dextrans colocalized in disconnected axonal bulbs. At this time-point, dextrans also persisted within single-labeled, highly vacuolated/thin, and elongate axons. These studies confirm that axolemmal disruption and impaired AxT occur as distinct non-related events early in the pathogenesis of TAI. Further, these studies provide evidence that the process of impaired axonal transport and subsequent axonal disconnection leads to delayed axolemmal instability, rather than proceeding as a consequence of initial axolemmal failure. This finding underscores the need of multiple approaches to fully assess the axonal response to TBI.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15473980     DOI: 10.1016/j.expneurol.2004.05.022

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  37 in total

1.  Rapid neuroinflammatory response localized to injured neurons after diffuse traumatic brain injury in swine.

Authors:  Kathryn L Wofford; James P Harris; Kevin D Browne; Daniel P Brown; Michael R Grovola; Constance J Mietus; John A Wolf; John E Duda; Mary E Putt; Kara L Spiller; D Kacy Cullen
Journal:  Exp Neurol       Date:  2017-01-09       Impact factor: 5.330

2.  Spatiotemporal evolution of apoptotic neurodegeneration following traumatic injury to the developing rat brain.

Authors:  Philip V Bayly; Krikor T Dikranian; Erin E Black; Chainllie Young; Yue-Qin Qin; Joann Labruyere; John W Olney
Journal:  Brain Res       Date:  2006-07-05       Impact factor: 3.252

Review 3.  How to Translate Time: The Temporal Aspects of Rodent and Human Pathobiological Processes in Traumatic Brain Injury.

Authors:  Denes V Agoston; Robert Vink; Adel Helmy; Mårten Risling; David Nelson; Mayumi Prins
Journal:  J Neurotrauma       Date:  2019-03-07       Impact factor: 5.269

4.  Strong Correlation of Genome-Wide Expression after Traumatic Brain Injury In Vitro and In Vivo Implicates a Role for SORLA.

Authors:  Michael R Lamprecht; Benjamin S Elkin; Kartik Kesavabhotla; John F Crary; Jennifer L Hammers; Jimmy W Huh; Ramesh Raghupathi; Barclay Morrison
Journal:  J Neurotrauma       Date:  2016-04-19       Impact factor: 5.269

5.  Differential effects of FK506 on structural and functional axonal deficits after diffuse brain injury in the immature rat.

Authors:  Ann Mae Dileonardi; Jimmy W Huh; Ramesh Raghupathi
Journal:  J Neuropathol Exp Neurol       Date:  2012-11       Impact factor: 3.685

6.  Therapy development for diffuse axonal injury.

Authors:  Douglas H Smith; Ramona Hicks; John T Povlishock
Journal:  J Neurotrauma       Date:  2013-02-14       Impact factor: 5.269

7.  Vagus nerve stimulation to augment recovery from severe traumatic brain injury impeding consciousness: a prospective pilot clinical trial.

Authors:  Chen Shi; Steven R Flanagan; Uzma Samadani
Journal:  Neurol Res       Date:  2013-04       Impact factor: 2.448

8.  Dorsal root compression produces myelinated axonal degeneration near the biomechanical thresholds for mechanical behavioral hypersensitivity.

Authors:  Raymond D Hubbard; Beth A Winkelstein
Journal:  Exp Neurol       Date:  2008-05-17       Impact factor: 5.330

Review 9.  Stimulating neuroregeneration as a therapeutic drug approach for traumatic brain injury.

Authors:  Bernhard K Mueller; Reinhold Mueller; Hans Schoemaker
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

10.  HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage.

Authors:  Jin Young Kim; Siming Shen; Karen Dietz; Ye He; Owain Howell; Richard Reynolds; Patrizia Casaccia
Journal:  Nat Neurosci       Date:  2009-12-27       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.